Dr Reddy's executive says aim to launch generic semaglutide for obesity in next few months in India
AI Briefing
- Dr. Reddy's to launch generic semaglutide for obesity treatment in India
- Generic version of Novo Nordisk's Wegovy expected to be available in next few months
- Company plans to supply the drug to Indian market through its existing network of distributors and wholesalers
Advertisement